Clinical Trial Update: A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO) [Phase 3]

View source ↗

Summary

Phase III trial update for Fruquintinib in multilined colorectal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED